Skip to content

Public FDA record

Z-0476-2022: Wireless Footswtich used with the following Philips Allura Xper and Azurion Interventional Fluoroscopic X

Recall record Z-0476-2022 for Philips North America Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0476-2022
Company in FDA record
Philips North America Llc
FDA classification date
Jan 10, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Wireless foot switch connection issues causing interruption of Fluoroscopy and exposure

Source facts

Action
Philips notified customers via an Urgent Medical Device Correction letter on October 29th, 2021 via Certified Mail. Letters outside of the U.S.A. will be distributed through the Philips Markets Organizations. Letter states reason for recall, health risk and actions that should be taken by the user in order to prevent risks for patients or users " Ensure that the wired foot switch is always connected to the system. The wired foot switch is always provided with the Allura Xper and the Azurion systems. " Immediately start using the wired foot switch in case the wireless foot switch loses connection. " Circulate this notice to all users of this device so that they are aware of the issue. " Place this Medical Device Correction with the documentation of the Philips Allura Xper or Azurion system. " Return the attached reply form to Philips to confirm that: the Allura Xper and Azuarion system wired foot switch is connected to the system the users of the system have reviewed and understood this Medical Device Correction. S. The actions planned by Philips IGT Systems to correct the problem You will be contacted by your local Philips representative as soon as this solution is available. If you need any further information or support concerningthis issue, please contact your local Philips representative. Technical Support Line: 1-800-722-9377
Initiated
2021-10-29
Root cause
Device Design
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Australia, Austria, Bangladesh, Belgium, Chile, China, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, French Polynesia, Germany, Greece, Hong Kong, Hungary, India, Iran, Ireland, Israel, Italy, Japan, Korea, Republic of Kuwait, Latvia, Lebanon, Mexico, Netherlands, New Zealand, Norway, Oman, Pakistan, Palestine, State of Philippines, Poland, Portugal, R¿union, Romania, RUMANIA, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, UZBEKISTAN, Viet Nam.
Recall number
Z-0476-2022
Recall status
Open, Classified
CDRH record ID
190369
FDA classified
2022-01-10
Recall event number
89044

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗